Induction Treatment With Cyclophosphamide, Thalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma: A Phase II Study

2010 ◽  
Vol 10 (1) ◽  
pp. 62-67 ◽  
Author(s):  
Deok-Hwan Yang ◽  
Yeo-Kyeoung Kim ◽  
Sang-Kyun Sohn ◽  
Joo-Seop Chung ◽  
Young-Don Joo ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Induction Treatment ◽  
Newly Diagnosed

scholarly journals Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Carthadex trial

Haematologica ◽  
2019 ◽  
Vol 104 (11) ◽  
pp. 2265-2273 ◽  
Author(s):  
Ruth Wester ◽  
Bronno van der Holt ◽  
Emelie Asselbergs ◽  
Sonja Zweegman ◽  
Marie Jose Kersten ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Phase Ii ◽  
Low Dose ◽  
Phase Ii Study ◽  
Newly Diagnosed

scholarly journals Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma

2019 ◽  
Vol 94 (5) ◽  
pp. 539-545 ◽  
Author(s):  
Peter A. Forsberg ◽  
Adriana C. Rossi ◽  
Angelique Boyer ◽  
Linda Tegnestam ◽  
Roger N. Pearse ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Newly Diagnosed ◽  
Dexamethasone Therapy

scholarly journals Phase II study of pegylated liposomal doxorubicin, low-dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple myeloma

2014 ◽  
Vol 89 (1) ◽  
pp. 62-67 ◽  
Author(s):  
Rachid C. Baz ◽  
Kenneth H. Shain ◽  
Mohamad A. Hussein ◽  
Ji-Hyun Lee ◽  
Daniel M. Sullivan ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Phase Ii ◽  
Low Dose ◽  
Liposomal Doxorubicin ◽  
Phase Ii Study ◽  
Pegylated Liposomal Doxorubicin ◽  
Newly Diagnosed
Sign in / Sign up

Export Citation Format

Share Document